Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
106.87
-1.59 (-1.47%)
Dec 9, 2025, 4:00 PM EST - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $6.14 billion as of December 9, 2025. Its market cap has decreased by -21.33% in one year.
Market Cap
6.14B
Enterprise Value
5.97B
1-Year Change
-21.33%
Ranking
Category
Stock Price
$106.87
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $6.14B, an increase of 513.75%. That is a compound annual growth rate of 18.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 6.23B | -24.65% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | - |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
| Jun 25, 2015 | 999.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.12B |
| Johnson & Johnson | 485.81B |
| AbbVie | 395.22B |
| UnitedHealth Group | 292.71B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 240.81B |
| Thermo Fisher Scientific | 212.87B |